Lensar (LNSR) Cost of Revenue (2019 - 2026)
Lensar (LNSR) posted quarterly Cost of Revenue of $7.0 million for Q1 2026, little changed year-over-year from $7.0 million in Q1 2025, and down 22.47% quarter-over-quarter from $9.1 million in Q4 2025.
Lensar (LNSR) Cost of Revenue (2019 - 2026) Analysis & Trends
Lensar (LNSR) has reported Cost of Revenue for 8 consecutive years, with $7.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Cost of Revenue changed 0.17% year-over-year to $7.0 million; the TTM figure through Mar 2026 stood at $31.3 million (up 5.28% YoY), while the FY2025 annual figure was $31.3 million, up 13.28% from the prior year.
- Cost of Revenue slipped to $7.0 million in Q1 2026 per LNSR's latest filing, from $9.1 million in the prior quarter.
- Across five years, Cost of Revenue topped out at $9.6 million in Q4 2024 and bottomed at $3.1 million in Q2 2022.
- Historically, Cost of Revenue has averaged $6.0 million across 5 years, with a median of $5.8 million in 2024.
- Annual changes were most pronounced in 2022 — Cost of Revenue slumped 32.94% — and 2023, when it surged 85.49%.
- Lensar's Cost of Revenue stood at $3.8 million in 2022, then soared by 85.49% to $7.0 million in 2023, then surged by 38.34% to $9.6 million in 2024, then retreated by 5.56% to $9.1 million in 2025, then decreased by 22.47% to $7.0 million in 2026.
- Business Quant data shows LNSR's Cost of Revenue at $7.0 million in Q1 2026, $9.1 million in Q4 2025, and $8.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.50 Bn | 194.89 Bn | 7.27 Bn | 5.33 Bn |
| 2 | Stryker | 130.00 Bn | 126.52 Bn | 4.50 Bn | 2.09 Bn |
| 3 | Medtronic | 120.36 Bn | 111.14 Bn | 6.41 Bn | 3.40 Bn |
| 4 | Boston Scientific | 74.19 Bn | 73.65 Bn | 3.85 Bn | 1.59 Bn |
| 5 | Edwards Lifesciences | 52.73 Bn | 48.48 Bn | 1.35 Bn | 392.40 Mn |
| 6 | Dexcom | 34.64 Bn | 32.70 Bn | 830.00 Mn | 478.40 Mn |
| 7 | GE HealthCare Technologies | 34.13 Bn | 32.02 Bn | 2.18 Bn | 2.25 Bn |
| 8 | Koninklijke Philips | 26.52 Bn | 23.20 Bn | 4.55 Bn | 2.57 Bn |
| 9 | Steris | 23.23 Bn | 22.75 Bn | 684.20 Mn | 808.60 Mn |
| 10 | Lensar | 105.02 Mn | 91.45 Mn | 9.78 Mn | 6.72 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 6.72 Mn |
| Jun 30, 2026 | 6.72 Mn |
| Mar 31, 2026 | 7.05 Mn |
| Mar 31, 2026 | 7.05 Mn |
| Dec 31, 2025 | 9.09 Mn |
| Dec 31, 2025 | 9.09 Mn |
| Sep 30, 2025 | 8.28 Mn |
| Sep 30, 2025 | 8.28 Mn |
| Jun 30, 2025 | 6.91 Mn |
| Jun 30, 2025 | 6.91 Mn |
| Mar 31, 2025 | 7.03 Mn |
| Mar 31, 2025 | 7.03 Mn |
| Dec 31, 2024 | 9.62 Mn |
| Dec 31, 2024 | 9.62 Mn |
| Sep 30, 2024 | 7.27 Mn |
| Sep 30, 2024 | 7.27 Mn |
| Jun 30, 2024 | 5.82 Mn |
| Jun 30, 2024 | 5.82 Mn |
| Mar 31, 2024 | 4.92 Mn |
| Mar 31, 2024 | 4.92 Mn |